Cite
HARVARD Citation
Bukong, T. et al. (n.d.). Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease. Hepatology. 64 (4), pp. 1057-1071. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Bukong, T. et al. (n.d.). Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease. Hepatology. 64 (4), pp. 1057-1071. [Online].